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In  this  edition,  we  will  be  focussing  on  two  of  the  most  impor-
tant  blood  diseases  in  both  Mexico  and  worldwide:  anaemia
and  leukaemia.  First,  anaemia.  According  to  Benoist  et  al.,
(based  on  data  collected  by  the  World  Health  Organiza-
tion)  worldwide  prevalence  of  anaemia  is  alarming:  1620
million  people  are  carriers  of  anaemia  (24.8%  of  the  total
population).  The  largest  population  groups  affected  by  the
disease  are  women  of  childbearing  age  (41.8%  [56  million]
pregnant;  30.2%  [468  million]  non-pregnant)  and  children
(47.7%  [293  million]  preschool;  25.4%  [305]  school  age).1
The  situation  in  Mexico  reﬂects  that  of  most  developing
countries  In  2012,  Shamah-Levy  et  al.  found  the  national
prevalence  among  non-pregnant  women  to  be  11.6%,  and
17.9%  among  pregnant  women.2 In  the  same  year,  Vanesa
de  la  Cruz-Góngora  et  al.,  studying  a  paediatric  popula-
tion,  found  a  23.3%  prevalence  of  anaemia  among  the  1  --
4-year  group,  10.1%  among  the  5-11-year  group,  and  5.6%
in  children  over  the  age  of  12  years,  in  contrast  to  adoles-
cents  (7.7%  in  girls  and  3.6%  in  boys).3 Despite  an  apparent
decrease  in  prevalence  in  Mexico,  anaemia  continues  to  be
a  public  health  problem  that  must  be  treated  at  the  earliest
opportunity.
Castellanos-Sinco,  in  a  review  of  deﬁciency  anaemia,
describes  the  pathophysiology  of  megaloblastic  anaemias,
highlighting  the  importance  of  folic  acid-vitamin  B12
metabolism.  The  author  stresses  the  importance  of  a  correct
use  and  interpretation  of  laboratory  tests,  and  evaluates  the
different  therapeutic  strategies  used.
In  a  second  review  article,  Santoyo-Sanchez  presents
a  proposal  for  nutritional  recommendations  in  patients
with  deﬁciency  anaemia,  emphasising  that  iron  supplements
alone  are  not  sufﬁcient,  and  dietary  changes  must  be  made
to  maintain  therapeutic  effectiveness.
In  a  retrospective  study,  Barragán-Iban˜es  evaluates  the
therapeutic  effect  of  the  most  commonly  used  iron  formula-
tions  in  Mexico  in  a  cohort  of  121  patients.  The  author  shows
that  all  formulations  are  equally  effective,  but  that  ferrous
fumarate  in  monotherapy  has  the  lowest  rate  of  therapeutic
failure.
The  second  half  of  the  journal  is  devoted  to  original
articles  on  lymphoblastic  leukaemia,  one  of  the  most  com-
mon  forms  of  leukaemia  in  Mexico.  Lymphoblastic  leukaemia
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tric  population,  and  accounts  for  up  to  12%  of  all  cases
f  leukaemia  in  the  US  (60%  diagnosed  in  the  under-20  age
roup).  It  is  important  to  note  that  the  Hispanic  population
f  Mexico  have  a  high  risk  of  cancer,  including  lymphoblas-
ic  anaemia.  In  Mexico,  the  Registro  Histopatológico  de
eoplasias  Malignas  (Histopathological  Register  of  Malignant
umours)  records  around  1926  cases  per  year,  which  repre-
ents  a  rate  of  2 cases  per  100,000  inhabitants.4,5 Current
nderstanding  of  the  disease  is  based  on  the  recognition  and
dentiﬁcation  of  various  genes  that,  due  to  their  oncogenic
otential,  are  indicators  of  poor  prognosis.  Perhaps  the  best-
nown  of  these  is  the  BCR-ABL1  oncogene,  which  is  detected
ore  frequently  in  older  patients.  Less  than  5%  of  paediatric
atients  have  this  gene,  25%  to  35%  of  adults,  and  up  to  50%
f  elderly  leukaemia  patients.
One  of  the  main  lines  of  research  pursued  by  haema-
ologists  in  our  hospital  concerns  acute  leukaemias.  Olarte
t  al.  found  the  frequency  of  BCR-ABL  p190  expression
mong  the  Mexican  population  treated  in  the  General  Hos-
ital  of  Mexico  to  be  14%  lower  than  the  rate  reported
n  Europe,  but  higher  than  that  reported  in  Latin  America
egisters.
On  the  subject  of  haematology,  Barranco  --Lampón,  in
n  original  article,  evaluates  the  risk  of  central  nervous
ystem  inﬁltration  in  repeated  traumatic  lumbar  puncture.
epeated  traumatic  lumbar  puncture  increases  the  relative
isk  of  central  nervous  system  inﬁltration  in  both  adults  and
hildren.  To  reduce  the  risk,  therefore,  every  effort  should
e  made  to  ensure  the  procedure  is  performed  by  trained
pecialists  with  ample  experience  in  the  technique.
On  the  subject  of  benign  pathology,  Ramos-Pen˜aﬁel
resents  an  article  on  the  beneﬁts  of  adding  androgens  to
mmunosuppressants  in  patients  with  aplastic  anemia.  This
trategy  was  ﬁrst  described  over  30  years  ago  in  Mexico  by
anchez-Medal.  However,  following  the  introduction  of  dif-
erent  immunosuppressant  drugs,  androgens  were  largely
idelined  until  the  early  years  of  the  21st  century,  when
oung  et  al.  determined  that  the  main  beneﬁt  of  androgens
ies  in  their  ability  to  shorten  telomeres.  This  brought  these
ompounds  back  into  mainstream  practice,  and  vindicated
heir  true  mechanism  of  action.
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Finally,  Espinoza-Elizondo  presents  a  case  study  in  essen-
ial  thrombocythemia  in  a  3-year  old  girl  to  highlight  the
iagnosis  of  thrombocytosis  in  paediatric  patients.
This  edition  of  our  journal  includes  review  studies  of
articular  importance  for  both  specialists  and  primary  care
hysicians,  with  evidence-based  information  on  the  impor-
ance  of  nutritional  support  in  patients  with  anaemia.  It  also
ncludes  original  research  articles  highlighting  the  concept
f  translational  medicine,  which  ultimately  aims  to  bridge
he  gap  between  the  laboratory  and  clinical  practice.
The  review  articles,  original  articles,  and  the  case  study
resented  in  this  edition  illustrate  some  of  the  research
ines  pursued  by  the  Haemtology  department  of  our  hos-
ital  and  the  contribution  made  by  this  group  of  clinicians
nd  researchers  to  the  well  being  of  patients  suffering  from
lood-related  diseases.  They  are  of  key  interest  not  only  to
aematologists,  but  to  all  physicians  with  an  interest  in  this
eld.
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